查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1471327

小分子原料药市场：按类型、产品、应用分类 - 2024-2030 年全球预测

Small-Molecule APIs Market by Type (Biological, Synthetic), Production (Contract Manufacturing, In-House Manufacturing), Application - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年小分子原料药市场规模为1,843.2亿美元，预估2024年将达1,973.5亿美元，2030年将达3,011.9亿美元，复合年增长率为7.26%。

小分子活性药物成分是低分子量的有机化合物，通常小于 900 道尔顿。这些分子是药物中的活性成分，在给予患者时负责引发预期的治疗效果。小分子原料药由于尺寸小、结构简单，可以轻鬆地跨细胞膜扩散，这使得它们在靶向细胞内位点时特别有效。癌症、心血管疾病和感染疾病等慢性疾病的增加促进了市场的成长。药物开发週期的加速和全球学名药的普及正在推动小分子原料药的使用。然而，与药物开发相关的高成本和严格的监管标准限制了市场的成长。此外，接触活性药物成分对健康的影响正在阻碍市场成长。然而，将生产外包到具有成本效益的地点、开发复杂的合成方法以及在药物发现中利用人工智慧等策略可能会改变这个充满机会的行业的游戏规则。由于学名药的迅速普及和受託製造的扩张，有进一步的成长机会。

主要市场统计
基准年[2023] 1843.2亿美元
预测年份 [2024] 1973.5亿美元
预测年份 [2030] 3011.9亿美元
复合年增长率（%） 7.26%

减少类型副作用增加对生物主题的倾向

生物来源小分子原料药来自或含有生物成分。这些 API 通常透过生物技术方法生产，例如重组 DNA 技术、受控基因表现、抗体技术和发酵製程。与合成原料药相比，生物原料药通常在结构上更加复杂，并且可以提供独特的治疗优势，例如更高的特异性和更少的副作用。合成小分子原料药是透过各种化学合成过程化学製造的。由于相对容易製造、扩充性以及药物开发中化学合成的丰富历史，该领域在小分子原料药市场占据主导地位。与生物原料药相比，合成原料原料药的生产量更大，成本更低。合成原料原料药涵盖广泛的学名药和非处方药，对于治疗许多疾病至关重要。

增加内部製造以确保生产品质标准

契约製造组织（CMO）在小分子原料药市场中发挥着至关重要的作用。 CMO 为出于各种原因希望委託製造的製药公司提供製造服务，这些原因包括节省成本、缺乏内部设备或需要专业知识。契约製造具有更大的灵活性，有助于管理与小分子原料药製造相关的复杂问题，例如法规遵循和品管。内部生产是指製药公司持有自己的低分子原料药生产设施。该细分市场包括拥有广泛资源和基础设施的大型製药公司，能够支持从原料药合成到最终产品配方的整个药品製造流程。内部製造可以更好地控制製造过程，有可能增加製造和研发的整合，并在智慧财产权保护和供应链管理方面提供策略优势。

应用：肿瘤学领域的不断进步将提高小分子原料药的利用率。

用于治疗CVD的小分子药物包括抗高血压药物、抗凝血药物和降胆固醇药物。全球心臟病、高血压和中风的高盛行率推动了对这些原料药的需求，因此需要强大的心血管治疗产品线。由于全球 1 型和 2 型糖尿病盛行率不断增加，与糖尿病相关的原料药正在扩大。胰岛素增敏剂、磺酰尿素和 SGLT2 抑制剂等小型分子药物对于控制血糖值和预防糖尿病相关併发症至关重要。免疫性疾病包括自体免疫疾病、过敏等多种疾病。用于治疗这些疾病的小分子原料药包括免疫抑制剂、发炎剂和抗组织胺药物。肿瘤学是小分子原料药市场最重要且发展最快的领域之一。对有效癌症治疗的迫切需求推动了对肿瘤原料药的需求。小分子化疗、激酶抑制剂和荷尔蒙疗法是癌症治疗方法中使用的原料药。

区域洞察

美洲地区的特点是强大的製药业、先进的医疗基础设施以及对研发的高度重视。领先的製药公司和尖端生物技术公司的存在促进了对小分子原料药的高需求。美国食品药物管理局(FDA) 的严格监管确保了高品质标准，使美国地区成为原料药生产的一个有吸引力的地点。欧洲是小分子原料药的主要市场，并拥有成熟的製药业。欧洲国家以其对药品创新和生产的重大贡献而闻名。欧洲药品管理局（EMA）在监管原料药的品质和安全方面发挥重要作用，创造了高度监管的市场环境。此外，欧洲的战略贸易协定和对学名药的强烈关注正在推动该地区对小分子原料药的需求。在中东和非洲地区，文明病的盛行率不断上升以及政府改善医疗保健系统的倡议是刺激市场成长的因素。在中国、日本和印度等新兴国家的推动下，亚太地区小分子 API 市场正在快速成长。由于较低的生产成本、熟练的劳动力以及医疗基础设施投资的增加，这些国家正在成为原料药製造的全球中心。该地区人口众多，慢性病盛行，也导致药品和原料药的需求增加。

FPNV定位矩阵

FPNV定位矩阵对于评估小分子原料药市场至关重要。我们检视与业务策略和产品满意度相关的关键指标，以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估，供应商被分为四个成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可以对小分子原料药市场供应商的现状进行深入而深入的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献，以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外，该分析还提供了对该行业竞争特征的宝贵见解，包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。详细程度的提高使供应商能够做出更明智的决策并制定有效的策略，从而在市场上获得竞争优势。

本报告对以下几个方面提供了宝贵的见解：

1. 市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2. 市场开拓：我们深入研究利润丰厚的新兴市场，并分析其在成熟细分市场的渗透率。

3. 市场多元化：提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。

4.竞争力评估与资讯：对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况、製造能力等进行全面评估。

5. 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告解决了以下关键问题：

1.小分子原料药市场规模及预测是多少？

2.小​​分子原料药市场预测期间需要考虑投资的产品、细分市场、应用和领域有哪些？

3.小分子原料药市场的技术趋势与法规结构是什么？

4.小分子原料药市场主要厂商的市场占有率是多少？

5.进入小分子原料药市场合适的型态与策略手段是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 全球慢性病的增加和老年人口的增加
      • 全球对学名药的需求增加
    • 抑制因素
      • 小分子原料药相关的高成本
    • 机会
      • 药物发现和开发的持续进步
      • 与生物製药公司合作进行联合治疗
    • 任务
      • 药物研发严格的监管要求
  • 市场区隔分析
    • 类型：由于副作用较少，生物基小分子原料药的趋势日益增强
    • 生产：增加内部製造以确保品质标准
    • 应用：肿瘤学的不断进步将提高小分子原料药的利用率。
  • 市场扰动分析
  • 波特五力分析
  • 价值炼和关键路径分析
  • 价格分析
  • 技术分析
  • 专利分析
  • 贸易分析
  • 法规结构分析

第六章小分子原料药市场：依类型

  • 生物
  • 合成

第七章 小分子原料药市场创建者

  • 合约起草（名词
  • 内部製造

第八章小分子原料药市场：依应用分类

  • 心血管
  • 糖尿病
  • 免疫疾病
  • 肿瘤学

第九章美洲小分子原料药市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太小分子原料药市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章欧洲、中东和非洲小分子原料药市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • Granules投资2.5亿美元新建绿色小分子API生产设施
    • SST Corporation与Viwit Pharmaceuticals建立策略联盟
    • API 与滑铁卢大学科学家合作开发针对冠状病毒的广谱小分子疗法
  • 战略分析和建议

第13章竞争产品组合

  • 主要企业简介
  • 主要产品系列
Product Code: MRR-43539E5D3217

[185 Pages Report] The Small-Molecule APIs Market size was estimated at USD 184.32 billion in 2023 and expected to reach USD 197.35 billion in 2024, at a CAGR 7.26% to reach USD 301.19 billion by 2030.

Small-molecule Active Pharmaceutical Ingredients are organic compounds with a low molecular weight, typically below 900 daltons. These molecules are the active components in pharmaceuticals that are responsible for eliciting the intended therapeutic effect when administered to patients. Small-molecule APIs can easily diffuse across cell membranes because of their small size and simple structure, making them particularly effective in targeting intracellular sites. Growing chronic disease prevalence, including cancer, cardiovascular, and infectious diseases, contributes to the market growth. Accelerated drug development cycles and rising adoption of generic drugs across the globe boost the utilization of small-molecule API. However, high costs and stringent regulatory standards associated with drug development limit the growth of the market. In addition, the health effects of exposure to active pharmaceutical ingredients create hindrances to market growth. However, strategies such as outsourcing production to cost-effective locations, developing sophisticated synthesis methods, and leveraging AI in drug discovery can be potential game-changers for an industry ripe with opportunity. Further growth opportunities exist due to the burgeoning generic drugs popularity and expanding contract manufacturing sectors.

KEY MARKET STATISTICS
Base Year [2023] USD 184.32 billion
Estimated Year [2024] USD 197.35 billion
Forecast Year [2030] USD 301.19 billion
CAGR (%) 7.26%

Type: Growing inclination towards biological based small-molecule APIs due to its reduced side effects

Biological small-molecule APIs are derived from living organisms or contain components of living organisms. These APIs are typically produced through biotechnological methods, including recombinant DNA technology, controlled gene expression, antibody technologies, and fermentation processes. Biological APIs are often more complex in structure compared to their synthetic counterparts and may offer unique therapeutic benefits, such as high specificity and reduced side effects. Synthetic small-molecule APIs are chemically manufactured through various chemical synthesis processes. This segment dominates the small-molecule APIs market due to the relative ease of production, scalability, and the extensive history of chemical synthesis in drug development. Synthetic APIs can be produced in large quantities and at a lower cost compared to biological APIs. They encompass a wide range of drugs, including generics and over-the-counter medications, and are critical in treating a multitude of conditions.

Production: Increasing in-house small-molecule APIs manufacturing to ensure quality standards

Contract manufacturing organizations (CMOs) play a pivotal role in the small-molecule APIs market. They offer their manufacturing services to pharmaceutical companies that prefer to outsource production for various reasons, such as cost reduction, lack of in-house facilities, or the need for specialized expertise. Contract manufacturing allows for greater flexibility and can help companies manage the complexities associated with the production of small-molecule APIs, including regulatory compliance and quality control. In-house manufacturing refers to pharmaceutical companies that maintain their own production facilities for small-molecule APIs. This segment includes large pharmaceutical companies with extensive resources and infrastructure that can support the entire drug manufacturing process, from API synthesis to final product formulation. In-house manufacturing allows for greater control over the production process, potentially leading to better integration of manufacturing and R&D efforts, and can provide a strategic advantage in terms of protecting intellectual property and supply chain management.

Application: Ongoing advancements in oncology enhances the utilization of small-molecule APIs

Small-molecule drugs used in the treatment of CVDs include antihypertensives, anticoagulants, and cholesterol-lowering drugs, among others. The demand for these APIs is driven by the high global prevalence of heart disease, hypertension, and stroke, necessitating a robust pipeline of cardiovascular medications. Diabetes-related APIs are expanding due to the increasing incidence of Type 1 and Type 2 diabetes worldwide. Small-molecule drugs such as insulin sensitizers, sulfonylureas, and SGLT2 inhibitors are essential in managing blood glucose levels and preventing complications associated with diabetes. Immunological disorders encompass a wide range of conditions, including autoimmune diseases and allergies. Small-molecule APIs used in the treatment of these disorders include immunosuppressants, anti-inflammatory drugs, and antihistamines. Oncology is one of the most critical and rapidly evolving segments in the small-molecule APIs market. The demand for oncology APIs is driven by the urgent need for effective cancer treatments. Small-molecule chemotherapeutic agents, kinase inhibitors, and hormone therapies are among the APIs used in cancer treatment regimens.

Regional Insights

The American region is characterized by a robust pharmaceutical industry, advanced healthcare infrastructure, and a strong focus on research and development. The presence of major pharmaceutical companies, along with cutting-edge biotechnology firms, contributes to the high demand for small-molecule APIs. Stringent regulations by the U.S. Food and Drug Administration (FDA) ensure high-quality standards, making American regions an attractive location for API manufacturing. Europe stands as a key market for small-molecule APIs, with a well-established pharmaceutical sector. European countries are known for their significant contributions to pharmaceutical innovation and production. The European Medicines Agency (EMA) plays a crucial role in regulating API quality and safety, fostering a highly regulated market environment. Additionally, Europe's strategic trade agreements and a strong emphasis on generic drugs bolster the demand for small-molecule APIs in the region. The increasing incidence of lifestyle-related diseases and government initiatives to improve healthcare systems are factors that could stimulate market growth across the Middle East and Africa. The APAC region is witnessing rapid growth in the small-molecule API market, driven by emerging economies such as China, Japan, and India. These countries are becoming global hubs for API manufacturing due to lower production costs, skilled labor, and increasing investments in healthcare infrastructure. The region's large population base and growing prevalence of chronic diseases also contribute to the rising demand for pharmaceuticals and APIs.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Small-Molecule APIs Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Small-Molecule APIs Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Small-Molecule APIs Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Agilent Technologies, Inc., Alacrita Holdings Limited, Albemarle Corporation, Aspen Group, Astrazeneca PLC, Aurobindo Pharma Limited, Bachem Holding AG, Bio-Rad Laboratories, Inc., Boehringer Ingelheim GmbH, Bristol-Myers Squibb, Cambrex Corporation by Permira funds, Carlyle Group, Charles River Laboratories International, Inc., Deciphera Pharmaceuticals, Inc., Dr. Reddy's Laboratories Ltd., F. Hoffmann-La Roche Ltd,, Gilead Sciences, Inc, GlaxoSmithKline PLC, Koninklijke DSM N.V., Lonza Group AG, Merck KGaA, Pfizer, Inc., and Teva Pharmaceutical Industries Ltd..

Market Segmentation & Coverage

This research report categorizes the Small-Molecule APIs Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Biological
    • Synthetic
  • Production
    • Contract Manufacturing
    • In-House Manufacturing
  • Application
    • Cardiovascular
    • Diabetes
    • Immunological Disorders
    • Oncology
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Small-Molecule APIs Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Small-Molecule APIs Market?

3. What are the technology trends and regulatory frameworks in the Small-Molecule APIs Market?

4. What is the market share of the leading vendors in the Small-Molecule APIs Market?

5. Which modes and strategic moves are suitable for entering the Small-Molecule APIs Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing prevalence of chronic diseases coupled with increasing geriatric population globally
      • 5.1.1.2. Rising demand for generic drugs worldwide
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with small-molecule APIs
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing advancements in drug discovery and development
      • 5.1.3.2. Collaborations with bio-pharmaceutical companies for combination therapies
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent regulatory requirements for drug development
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Growing inclination towards biological based small-molecule APIs due to its reduced side effects
    • 5.2.2. Production: Increasing in-house small-molecule APIs manufacturing to ensure quality standards
    • 5.2.3. Application: Ongoing advancements in oncology enhances the utilization of small-molecule APIs
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Small-Molecule APIs Market, by Type

  • 6.1. Introduction
  • 6.2. Biological
  • 6.3. Synthetic

7. Small-Molecule APIs Market, by Production

  • 7.1. Introduction
  • 7.2. Contract Manufacturing
  • 7.3. In-House Manufacturing

8. Small-Molecule APIs Market, by Application

  • 8.1. Introduction
  • 8.2. Cardiovascular
  • 8.3. Diabetes
  • 8.4. Immunological Disorders
  • 8.5. Oncology

9. Americas Small-Molecule APIs Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Small-Molecule APIs Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Small-Molecule APIs Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Granules Investing USD 250 Million for New Green Small-Molecule API Mfg Facility
    • 12.3.2. SST Corporation and Viwit Pharmaceuticals Establish Strategic Collaboration
    • 12.3.3. API partners with the University of Waterloo scientists to develop broad-spectrum small molecule therapeutics against coronaviruses
  • 12.4. Strategy Analysis & Recommendation

13. Competitive Portfolio

  • 13.1. Key Company Profiles
  • 13.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. SMALL-MOLECULE APIS MARKET RESEARCH PROCESS
  • FIGURE 2. SMALL-MOLECULE APIS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. SMALL-MOLECULE APIS MARKET DYNAMICS
  • FIGURE 7. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS SMALL-MOLECULE APIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS SMALL-MOLECULE APIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES SMALL-MOLECULE APIS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES SMALL-MOLECULE APIS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC SMALL-MOLECULE APIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC SMALL-MOLECULE APIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA SMALL-MOLECULE APIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA SMALL-MOLECULE APIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. SMALL-MOLECULE APIS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 22. SMALL-MOLECULE APIS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. SMALL-MOLECULE APIS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY BIOLOGICAL, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY BIOLOGICAL, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY SYNTHETIC, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY SYNTHETIC, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY CONTRACT MANUFACTURING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY CONTRACT MANUFACTURING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY IN-HOUSE MANUFACTURING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY IN-HOUSE MANUFACTURING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY DIABETES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY DIABETES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY IMMUNOLOGICAL DISORDERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY IMMUNOLOGICAL DISORDERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY ONCOLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. AMERICAS SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 30. AMERICAS SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 31. AMERICAS SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
  • TABLE 32. AMERICAS SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
  • TABLE 33. AMERICAS SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 34. AMERICAS SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 35. AMERICAS SMALL-MOLECULE APIS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 36. AMERICAS SMALL-MOLECULE APIS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 37. ARGENTINA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 38. ARGENTINA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 39. ARGENTINA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
  • TABLE 40. ARGENTINA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
  • TABLE 41. ARGENTINA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 42. ARGENTINA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 43. BRAZIL SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 44. BRAZIL SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 45. BRAZIL SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
  • TABLE 46. BRAZIL SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
  • TABLE 47. BRAZIL SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 48. BRAZIL SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 49. CANADA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 50. CANADA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 51. CANADA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
  • TABLE 52. CANADA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
  • TABLE 53. CANADA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 54. CANADA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 55. MEXICO SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 56. MEXICO SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 57. MEXICO SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
  • TABLE 58. MEXICO SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
  • TABLE 59. MEXICO SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 60. MEXICO SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 61. UNITED STATES SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 62. UNITED STATES SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 63. UNITED STATES SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
  • TABLE 64. UNITED STATES SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
  • TABLE 65. UNITED STATES SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 66. UNITED STATES SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 67. UNITED STATES SMALL-MOLECULE APIS MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 68. UNITED STATES SMALL-MOLECULE APIS MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 69. ASIA-PACIFIC SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 70. ASIA-PACIFIC SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 71. ASIA-PACIFIC SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
  • TABLE 73. ASIA-PACIFIC SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 74. ASIA-PACIFIC SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 75. ASIA-PACIFIC SMALL-MOLECULE APIS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 76. ASIA-PACIFIC SMALL-MOLECULE APIS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 77. AUSTRALIA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 78. AUSTRALIA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 79. AUSTRALIA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
  • TABLE 80. AUSTRALIA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
  • TABLE 81. AUSTRALIA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 82. AUSTRALIA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 83. CHINA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 84. CHINA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 85. CHINA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
  • TABLE 86. CHINA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
  • TABLE 87. CHINA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 88. CHINA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 89. INDIA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 90. INDIA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 91. INDIA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
  • TABLE 92. INDIA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
  • TABLE 93. INDIA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 94. INDIA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 95. INDONESIA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 96. INDONESIA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 97. INDONESIA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
  • TABLE 98. INDONESIA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
  • TABLE 99. INDONESIA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 100. INDONESIA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 101. JAPAN SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 102. JAPAN SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 103. JAPAN SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
  • TABLE 104. JAPAN SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
  • TABLE 105. JAPAN SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 106. JAPAN SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 107. MALAYSIA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 108. MALAYSIA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 109. MALAYSIA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
  • TABLE 110. MALAYSIA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
  • TABLE 111. MALAYSIA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 112. MALAYSIA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 113. PHILIPPINES SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 114. PHILIPPINES SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 115. PHILIPPINES SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
  • TABLE 116. PHILIPPINES SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
  • TABLE 117. PHILIPPINES SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 118. PHILIPPINES SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 119. SINGAPORE SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 120. SINGAPORE SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 121. SINGAPORE SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
  • TABLE 122. SINGAPORE SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
  • TABLE 123. SINGAPORE SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 124. SINGAPORE SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 125. SOUTH KOREA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 126. SOUTH KOREA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 127. SOUTH KOREA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
  • TABLE 128. SOUTH KOREA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
  • TABLE 129. SOUTH KOREA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 130. SOUTH KOREA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 131. TAIWAN SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 132. TAIWAN SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 133. TAIWAN SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
  • TABLE 134. TAIWAN SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
  • TABLE 135. TAIWAN SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 136. TAIWAN SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 137. THAILAND SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 138. THAILAND SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 139. THAILAND SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
  • TABLE 140. THAILAND SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
  • TABLE 141. THAILAND SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 142. THAILAND SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 143. VIETNAM SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 144. VIETNAM SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 145. VIETNAM SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
  • TABLE 146. VIETNAM SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
  • TABLE 147. VIETNAM SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 148. VIETNAM SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA SMALL-MOLECULE APIS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA SMALL-MOLECULE APIS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 157. DENMARK SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 158. DENMARK SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 159. DENMARK SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
  • TABLE 160. DENMARK SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
  • TABLE 161. DENMARK SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 162. DENMARK SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 163. EGYPT SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 164. EGYPT SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 165. EGYPT SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
  • TABLE 166. EGYPT SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
  • TABLE 167. EGYPT SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 168. EGYPT SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 169. FINLAND SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 170. FINLAND SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 171. FINLAND SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
  • TABLE 172. FINLAND SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
  • TABLE 173. FINLAND SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 174. FINLAND SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 175. FRANCE SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 176. FRANCE SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 177. FRANCE SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
  • TABLE 178. FRANCE SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
  • TABLE 179. FRANCE SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 180. FRANCE SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 181. GERMANY SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 182. GERMANY SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 183. GERMANY SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
  • TABLE 184. GERMANY SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
  • TABLE 185. GERMANY SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 186. GERMANY SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 187. ISRAEL SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 188. ISRAEL SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 189. ISRAEL SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
  • TABLE 190. ISRAEL SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
  • TABLE 191. ISRAEL SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 192. ISRAEL SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 193. ITALY SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 194. ITALY SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 195. ITALY SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
  • TABLE 196. ITALY SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
  • TABLE 197. ITALY SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 198. ITALY SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 199. NETHERLANDS SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 200. NETHERLANDS SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 201. NETHERLANDS SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
  • TABLE 202. NETHERLANDS SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
  • TABLE 203. NETHERLANDS SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 204. NETHERLANDS SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 205. NIGERIA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 206. NIGERIA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 207. NIGERIA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
  • TABLE 208. NIGERIA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
  • TABLE 209. NIGERIA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 210. NIGERIA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 211. NORWAY SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 212. NORWAY SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 213. NORWAY SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
  • TABLE 214. NORWAY SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
  • TABLE 215. NORWAY SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 216. NORWAY SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 217. POLAND SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 218. POLAND SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 219. POLAND SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
  • TABLE 220. POLAND SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
  • TABLE 221. POLAND SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 222. POLAND SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 223. QATAR SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 224. QATAR SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 225. QATAR SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
  • TABLE 226. QATAR SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
  • TABLE 227. QATAR SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 228. QATAR SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 229. RUSSIA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 230. RUSSIA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 231. RUSSIA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
  • TABLE 232. RUSSIA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
  • TABLE 233. RUSSIA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 234. RUSSIA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 235. SAUDI ARABIA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 236. SAUDI ARABIA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 237. SAUDI ARABIA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
  • TABLE 238. SAUDI ARABIA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
  • TABLE 239. SAUDI ARABIA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 240. SAUDI ARABIA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 241. SOUTH AFRICA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 242. SOUTH AFRICA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 243. SOUTH AFRICA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
  • TABLE 244. SOUTH AFRICA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
  • TABLE 245. SOUTH AFRICA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 246. SOUTH AFRICA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 247. SPAIN SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 248. SPAIN SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 249. SPAIN SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
  • TABLE 250. SPAIN SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
  • TABLE 251. SPAIN SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 252. SPAIN SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 253. SWEDEN SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 254. SWEDEN SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 255. SWEDEN SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
  • TABLE 256. SWEDEN SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
  • TABLE 257. SWEDEN SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 258. SWEDEN SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 259. SWITZERLAND SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 260. SWITZERLAND SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 261. SWITZERLAND SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
  • TABLE 262. SWITZERLAND SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
  • TABLE 263. SWITZERLAND SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 264. SWITZERLAND SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 265. TURKEY SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 266. TURKEY SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 267. TURKEY SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
  • TABLE 268. TURKEY SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
  • TABLE 269. TURKEY SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 270. TURKEY SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 271. UNITED ARAB EMIRATES SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 272. UNITED ARAB EMIRATES SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 273. UNITED ARAB EMIRATES SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
  • TABLE 274. UNITED ARAB EMIRATES SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
  • TABLE 275. UNITED ARAB EMIRATES SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 276. UNITED ARAB EMIRATES SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 277. UNITED KINGDOM SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 278. UNITED KINGDOM SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 279. UNITED KINGDOM SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
  • TABLE 280. UNITED KINGDOM SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
  • TABLE 281. UNITED KINGDOM SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 282. UNITED KINGDOM SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 283. SMALL-MOLECULE APIS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 284. SMALL-MOLECULE APIS MARKET, FPNV POSITIONING MATRIX, 2023